Impact of BMI on serum estradiol and bone turnover markers in postmenopausal women with hormone-sensitive early breast cancer treated with anastrozole

By Kyvernitakis I.   Knöll D.   Struck M.   Hars O.   Bauer T.   Hadji P.  

Journal of Cancer Research and Clinical Oncology, Vol. 140, Iss. 1, 2014-01 ,pp. : 159-166

Springer Publishing Company

Access to resources Recommend Favorite

Apoptosis inhibition mediated by medroxyprogesterone acetate treatment of breast cancer cell lines

By Ory K.  

Breast Cancer Research and Treatment, Vol. 68, Iss. 3, 2001-08 ,pp. : 187-198

Springer Publishing Company

Access to resources Recommend Favorite

Dietary acrylamide intake and estrogen and progesterone receptor-defined postmenopausal breast cancer risk

By Pedersen Grete   Hogervorst Janneke   Schouten Leo   Konings Erik   Goldbohm R.   Brandt Piet  

Breast Cancer Research and Treatment, Vol. 122, Iss. 1, 2010-07 ,pp. : 199-210

Springer Publishing Company

Access to resources Recommend Favorite

Effects of Dietary Apigenin on Tumor Latency, Incidence and Multiplicity in a Medroxyprogesterone Acetate- Accelerated 7,12-Dimethylbenz(a)anthracene- Induced Breast Cancer Model

By Mafuvadze Benford   Cook Matthew   Xu Zhang   Besch-Williford Cynthia L.   Hyder Salman M.  

Nutrition and Cancer, Vol. 65, Iss. 8, 2013-11 ,pp. : 1184-1191

Routledge Ltd

Access to resources Recommend Favorite

Tamoxifen and megestrol acetate for postmenopausal breast cancer: Diverging effects on liver proteins, androgens, and glucocorticoids

By Löfgren L.   Wallberg B.   Wilking N.   Fornander T.   Rutqvist L.   Carlström K.   Schoultz B.   Schoultz E.  

Medical Oncology, Vol. 21, Iss. 4, 2004-12 ,pp. : 309-318

Humana Press, Inc

Access to resources Recommend Favorite